Medipattern Featured on the Next Biggest Winner

Attention: Business/Financial Editors

The Medipattern Corporation ("Medipattern" or the "Company") (TSX VENTURE:MKI),
will be featured on "The Next Biggest Winner" airing on iChannel TV on Thursday,
April 19 at 7:00 PM EST. You can listen to the segment, featuring Medipattern
CEO Jeff Collins, by visiting http://www.thenextbiggestwinner.com/medipattern/.
The Next Biggest Winner is a television interview series for Canadian investors
dedicated to identifying companies poised for growth. More information is listed
at the show's web site http://www.thenextbiggestwinner.com/episode-schedule/.


"Medipattern's proprietary new FDA approved 3D carotid rendering product
Visualize:Vascular(TM) technology, enables practitioners to better understand
the lumen in carotid arteries, aiding in the determination of who should go into
watchful medical observation and who requires surgery, thereby providing a
valuable life-saving tool for patients. Furthermore, the sooner luminal
reduction (plaque) is detected in the patient, the sooner the patient can be
treated with medication such as statins or some other options," stated Jeff
Collins, President and CEO of Medipattern. "Long term, it could be that the time
taken to do a standard carotid exam could be reduced to a fraction of the time
by utilizing the Visualize:Vascular(TM) protocol."


"The economics of using Visualize:Vascular(TM) product within a medical practice
are obvious because the practice is being reimbursed by insurance providers. The
bottom line is that there is value for everyone along the way, which is why we
continue to add more sites to our client roster," concluded Mr. Collins.


We welcome Lenox Hill Radiology (four sites), East Suffolk Cardiology (part of
the SUNY system at Stony Brook) and Massapequa Heart (part of the North Shore -
LIJ system) to the Medipattern family. Medipattern continues to expand its
network of clinics in the USA where Visualize:Vascular(TM) is available.
"Scanning volumes continue to rise week over week as the practices come on
line," added Mr. Collins.




Upcoming Events                                                             
The Breast Course              April 15 - 18, 2012     Lisbon, Portugal     
CAR Annual Meeting             April 26 - 29, 2012     Montreal, Quebec     
Annual Meeting - MHA           June 6 - 7, 2012        Brewster, MA         
SVU/SVS Annual Conference      June 7 - 9, 2012        Baltimore, MD        



About the Medipattern Corporation:

Medipattern(R) is a pioneer in the development of imaging software solutions
that help medical practitioners to better understand lesions and critical
anatomy. Medipattern uses its Cadenza(TM) technology to process images, finding
the salient region of interest and presenting them in 2D and 3D formats that
enhance the reader's perception. For more information, please visit the
Company's website: www.medipattern.com.


Medipattern(R) and B-CAD(R) are registered trademarks of The Medipattern
Corporation. Visualize:Vascular(TM) and Cadenza(TM) are trademarks of the
Medipattern Corporation. SonoCine is a registered trademark of SonoCine, Inc.


Forward-looking statements

This document contains forward-looking statements relating to Medipattern's
performance, operations, or business environment. These statements are based on
what we believe are reasonable assumptions given currently available information
and our understanding of Medipattern's current activities. We have tried,
whenever possible, to identify these forward-looking statements using words such
as "anticipates," "believes," "estimates," "expects," "plans," "intends,"
"potential", and similar expressions. Forward-looking statements are not
guarantees of future performance and involve risks and uncertainties that are
difficult to predict or control. A number of factors could cause actual outcomes
and results to differ materially from those expressed in forward-looking
statements. These factors include but are not limited to those set forth in the
Company's corporate filings, (posted at www.sedar.com). In addition, these
forward-looking statements relate to the date on which they are made. The
Company disclaims any intention or obligation to update or revise any
forward-looking statements for any reason. Readers should not rely on
forward-looking statements.